A Saudi startup is betting that the future of healthcare in the region will be proactive, not reactive. It is scaling a data-driven approach to proactive healthcare

Riyadh-based Madeed secured additional pre-seed funding from SEEDRA Ventures, Unity Investment Partners, and Seen Growth. This brings its total funding to USD 925 thousand. The round builds on earlier backing from Vision Ventures and a group of Saudi investors.

Why You Should Care

Preventive healthcare is still underdeveloped across much of the MENA region, where systems are often structured around treatment rather than early intervention.

Madeed’s model taps into a growing shift toward personalized, data-led health management, positioning itself at the intersection of AI, diagnostics, and lifestyle optimization. For founders and investors, this signals early movement in a category that could reshape how healthcare demand is generated and managed.

Riyadh-based Madeed has secured additional pre-seed funding, bringing its total pre-seed funding to USD 925 thousand. The round was led by SEEDRA Ventures, Unity Investment Partners, and Seen Growth. This follows an earlier USD 400 thousand round led by Vision Ventures.

Founded by Adam Bataineh, Madeed is a preventative health platform. It is building a longevity platform with a focus on true disease prevention and health optimization. It uses advanced laboratory testing to identify early risk signals across hundreds of diseases before symptoms appear.

The platform centers on preventive and personalized healthcare. It uses laboratory data and artificial intelligence to identify early indicators of potential health risks before symptoms emerge. 

“ We dedicated the past period to conducting the necessary operational tests on the platform to ensure its efficiency, smooth operation, and the integration of the services offered,” said Dr. Adam Bataineh, founder and CEO of Madeed,

Looking ahead, with the new capital, it aims to develop the platform’s products. It also aims to expand clinical and laboratory partnerships in the region, with an initial focus on the Saudi market. Additionally, it seeks to accelerate the platform’s growth and enable it to launch its services more broadly in Saudi Arabia.

The Ripple

Madeed’s raise comes as regional investors increasingly look toward healthtech as a long-term growth sector. Startups operating in diagnostics, wellness, and AI-driven healthcare are beginning to attract early-stage capital, particularly in Saudi Arabia, where healthcare transformation is a national priority.

The company’s partnership-led approach, especially with labs and clinical providers, also highlights how startups in this space may integrate into existing healthcare infrastructure rather than replace it. 

For investors, this could point to a more collaborative ecosystem where traditional providers and tech platforms evolve together.

What to Watch

As Madeed moves beyond its pilot phase, the focus will be on its broader rollout in Saudi Arabia and the expansion of its clinical and laboratory partnerships. The company has already onboarded 150 users during testing, and its next stage will show how that early traction translates at scale. 

The development of its platform and the rollout of its services will also indicate how preventive, personalized healthcare solutions are introduced into the local market.

More broadly, the company’s rollout will be an early test of how receptive the Saudi market is to preventive, subscription-based healthcare models, and whether this approach can expand across the wider region.